• BX Home
  • GlaxoSmithKline plc: News

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

GLAXOSMITHKLINE PLC

GlaxoSmithKline plc (GSK) is currently the second-largest pharmaceutical company in the world. Its pharmaceutical segment covers anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. The company produces the popular asthma medicine Advair. GSK’s consumer healthcare segment handles products such as oral healthcare, nutritional drinks, and over the counter medicines. Founded in 1935, GSK’s headquarters are located in Uxbridge, UK.

GlaxoSmithKline plc is part of Business Exchange, suggested by Ulli Muenker. This topic contains 756 news and 87 blog items. Read updated news, blogs, and resources about GlaxoSmithKline plc. Find user-submitted articles and reactions on GlaxoSmithKline plc from like-minded professionals.

News

Please add new articles to this topic

Conflict of interest fears over vaccine groupmore

Extract not available.

The Missing Link in Innovative Researchmore

R&D organizations have begun to create smaller, more accountable units, but that alone has proven insufficient.

Genetic Technologies Files New Patent Infringement Suit in USAmore

its primary non-coding patent against the following parties: Agilent Technologies Inc.; Bristol-Myers Squibb Company;...

Reportlinker Adds Innovations in Protein Kinase Therapies - Significan...more

5.3.3 Key Indications of Interest 53 5.3.4 First-in-Class and Combination Drugs 54 5.4 GlaxoSmithKline plc 62 5.4.

Cancer Research Grows in Chinamore

Ho, a medical doctor, graduated from Yale University before working in cancer-drug development at Johnson & Johnson...

Anacor Pharmaceuticals Announces Retirement Of Zhi Hong From Board Of ...more

is the Senior Vice President and Head of the Infectious Disease Center of Excellence for Drug Discovery at...

Return of business travel lifts Hogg Robinsonmore

Extract not available.

China���s Cancer Deaths Spur Merck Investment in Beijing Biotechmore

Ho, a medical doctor, graduated from Yale University before working in cancer-drug development at Johnson & Johnson...

Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Comingmore

a death sentence, killing 8,700 Americans a year. Now medicines from Roche, Daiichi, Bristol-Myers Squibb Co.

Biotech Calendar: 2011 FDA Drug Approvalsmore

also included. Optimer Pharmaceuticals(OPTR) Drug/indication: Dificid for Clostridium difficile infection FDA approval...

Whistleblower rule clears divided SECmore

has a long history in the United States. Last year the U.S. Department of Justice gave former GlaxoSmithKline Plc...

UPDATE 3-Whistleblower rule clears divided U.S. SECmore

has a long history in the United States. Last year the U.S. Department of Justice gave former GlaxoSmithKline Plc (GSK.

Wes Wheeler Appointed As CEO By Marken's Board Of Directorsmore

Pharmaceuticals International, and has previously held senior executive roles of increasing responsibility in...

Reportlinker Adds Drug Delivery Devices Market Outlook in India to 201...more

categories. Global corporate-level profiles of key companies operating within the India Drug Delivery Devicesmarket.

Reportlinker Adds Drug Delivery Devices Market Outlook in China to 201...more

Global corporate-level profiles of key companies operating within the China Drug Delivery Devices market.

Reportlinker Adds HIV-AIDS Therapeutics - Pipeline Assessment and Mark...more

Analysis of the current and future competition in the global HIV/AIDS therapeutics market. Key market players covered...

AstraZeneca to market Amgen drug with Daiichimore

sold in the U.S. under the brand name Prolia for treating osteoporosis. Amgen and U.K.-based GlaxoSmithKline PLC...

Emerging-Markets Business Offsets Generics: Glaxo CEOmore

GlaxoSmithKline is seeing strong growth from sales in emerging markets, offsetting declines in the U.S.

Theravance to Present at Investor Conferences in June 2011more

s key programs include: RELOVAIR(TM), LAMA/LABA ('719/vilanterol (VI)) and MABA (Bifunctional Muscarinic...

Video: GSK Going Globalmore

profits from less developed countries to improve health care; global opportunities, and new growth models, with Andrew...

UPDATE 2-AstraZeneca gets Japan boost with cancer drug dealmore

with other big drug companies. In addition to the tie-up with Daiichi, Amgen also has a deal with GlaxoSmithKline (GSK.

Buy GlaxoSmithKline Consumer; it has not fallen in the bear market: Su...more

Sudarshan Sukhani , Technical Trends in an interview with ET Now talks about GlaxoSmithKline Consumer.

Glaxo to reinvest ��3.5 million of Africa profits in healthcaremore

Andrew Witty, CEO of the drug giant GlaxoSmithKline, is making good on his promise to reinvest 20% of the corporation's...

Second Drug Wins Approval For Treatment of Hepatitis Cmore

competing with Dr. Bogers former company. Vertex did develop two H.I.V. drugs that were sold by GlaxoSmithKline, and it...

Valeant casts brusied egos aside, buys againmore

target was another generic producer that also had over-the-counter drugs. Earlier in 2010 Valeant also paid...

Top Sources: GlaxoSmithKline plc

  • Financial Times
  • Morningstar.com
  • BusinessWeek
  • MarketWatch
  • Reuters UK
  • Philadelphia Inquirer
  • TheStreet.com
  • Reuters
  • google.com
  • online.wsj.com

Most Active Users in this Topic

see all contributors in GlaxoSmithKline plc

Featured White Papers

Post a Job

Jobs in this Topic

High Frequency Trader World Financial Desk | New York, NY
Posted: Feb 10
Loan Officer, Baton Rouge and Seedco Financial Services | New Orleans, LA
Posted: Feb 3
Assistant VP for Accounting & Post Award Administration UT Southwestern Medical Center | Dallas, TX
Posted: Jan 30
Logistics Coordinator Ed&f Man | Miami, FL
Posted: Jan 20
Software Tester/QA Analyst Tntp | Brooklyn, NY
Posted: Jan 19

Report comment contains invalid characters. ()
cancel
Search Cancel